South Korea’s cosmetics industry has become a genuine global force, with annual exports surpassing $7 billion in recent years and the US consistently ranking among its top destination markets. Walk down any Sephora aisle, scroll #skincaretok for 90 seconds, or browse the skincare section of any major retailer, and the evidence is obvious: snail mucin, centella asiatica, layered essences, and glass-skin serums have fully arrived. Most of us have welcomed them.
But there’s a question almost nobody asks at the shelf: Whose rules does this product actually follow?
The answer is more complicated — and more consequential for your skin — than the charming packaging suggests.
Three Countries, Three Very Different Rulebooks
To understand the gap, you need to understand how differently South Korea, the European Union, and the United States approach cosmetics safety.
South Korea’s Ministry of Food and Drug Safety (MFDS) operates under the Cosmetics Act, most recently revised in 2020. Under this framework, most products are what regulators call “general cosmetics” — manufacturers are responsible for safety, and products don’t require pre-market government approval. But a special subcategory called functional cosmetics — products that claim to whiten skin, reduce wrinkles, provide UV protection, or address hair loss — do require MFDS review and registration before hitting shelves. For those specific claim categories, Korean regulation is actually more rigorous than the US.
The European Union takes the most aggressive stance of any major market. Regulation (EC) No 1223/2009 governs cosmetics across all 27 member states and maintains four regulatory annexes that collectively ban or restrict more than 1,300 substances from cosmetic use. Every product sold in the EU must have a designated Responsible Person (an EU-based entity), a documented Product Information File, and a safety assessment completed by a qualified professional before it can reach consumers. Pre-market safety review isn’t optional — it’s the baseline.
Then there’s the United States. The FDA’s authority over cosmetics was, until very recently, essentially unchanged since the Federal Food, Drug, and Cosmetic Act of 1938. For 85 years, there was no requirement for pre-market approval, no mandatory product registration, and the FDA maintained only 11 prohibited or restricted ingredient categories. That changed in December 2022 when Congress passed the Modernization of Cosmetics Regulation Act (MoCRA) — the first substantive update to US cosmetics law in eight decades. MoCRA requires facility registration, product listing, and adverse event reporting. But it still doesn’t require pre-market safety review of cosmetic ingredients, and it doesn’t establish anything close to the EU’s restricted substance list.
The number that matters most: 1,300+ vs. 11. That’s the EU-to-US gap in restricted cosmetic ingredients. K-beauty products entering the US market land squarely in that gap.
What That Gap Looks Like in Practice
This isn’t abstract regulatory trivia. There are specific ingredient categories where Korean-market formulations diverge sharply from what either the EU or FDA formally review.
Hydroquinone is the most discussed example. It’s used widely in Asia for skin brightening and appears in some K-beauty formulations marketed for “even tone” or “glass skin glow.” The EU prohibited hydroquinone from general cosmetics use via Directive 2000/6/EC — it’s still available as a prescription dermatological treatment, but not in over-the-counter skincare. The FDA, meanwhile, has been in regulatory limbo on hydroquinone for years. It has proposed reclassifying OTC hydroquinone products, but the status remains unresolved — meaning products containing it can still reach US consumers without any formal FDA evaluation of their safety.
Kojic acid, another common brightening ingredient in K-beauty, is largely unrestricted by the FDA. The EU’s Scientific Committee on Consumer Safety issued an opinion in 2021 setting a maximum concentration of 1% in face and hand products — a limit that doesn’t exist in US regulations. That means a formulation sold in the US might contain concentrations the EU specifically determined require a ceiling.
Sunscreen active ingredients tell a different but equally instructive story. Korean sunscreen technology is genuinely ahead of the US market — UV filters like Tinosorb S, Tinosorb M, and Uvinul A Plus have been approved in Korea and the EU for years. But they’ve been sitting in FDA review limbo since the early 2000s because sunscreens are regulated as OTC drugs in the US, not cosmetics, and the FDA requires a full New Drug Application process to approve new active ingredients. Paradoxically, some K-beauty sunscreens available in the US use filter technology the FDA hasn’t formally evaluated — while being demonstrably more photostable and broadly protective than many older US-approved filters. It’s a regulatory irony that frustrates dermatologists on both sides of the Pacific.
And then there’s “dermatologist tested” — a phrase that is essentially meaningless as a safety signal. It doesn’t specify what was tested, how many dermatologists participated, what concentrations were evaluated, or whether any regulatory body reviewed the methodology. It’s marketing language, not certification.
The Import Reality: What Happens When K-Beauty Enters the US
When a K-beauty product is imported for US sale — whether by a major distributor, a boutique importer, or a third-party Amazon seller — the FDA does not review the formula. There is no pre-market approval step. The agency can act after the fact if a product is found to be adulterated or if adverse events are reported through MoCRA’s new reporting requirements, but the default posture is reactive.
Under MoCRA, the FDA now has authority to order mandatory recalls for cosmetics for the first time — previously it relied entirely on voluntary recalls. Facility registration requirements began phasing in after 2024. But registration is exactly that: registration. It is not a safety review of formulations or ingredients.
Independent testing has flagged real problems with imported cosmetics. Testing data from accredited labs like Qalitex Laboratories has consistently shown that label claims and actual formulations don’t always match, even in products sold through major retail channels. Environmental Working Group campaigns testing skin-lightening creams sold in ethnic grocery stores and online marketplaces have found mercury concentrations exceeding the FDA’s 1 parts-per-million limit in some products — sometimes by factors of hundreds. Mercury is a banned cosmetic ingredient in the US, but enforcement depends entirely on products actually being tested after they’re already on shelves.
The system works when it works, but “when it works” requires someone to test something first.
What You Can Actually Do as a Consumer
None of this is an argument to clear your K-beauty shelf. Much of it is genuinely excellent — innovative, well-formulated, and often more interesting than equivalent US products. But it does mean shopping more deliberately.
-
Check ingredients against EU restrictions. Apps like INCI Decoder and the EWG’s Skin Deep database let you paste in an ingredient list and flag substances of concern. The EU’s restricted substance list is a useful benchmark even in the US — it represents decades of pre-market safety review that the FDA has not replicated. If a product wouldn’t pass EU Annex II, that’s worth knowing.
-
Scrutinize brightening and whitening products closely. This is the category where ingredient concentrations matter most and where regulatory divergence is sharpest. If a product promises dramatic brightening without any explanation of mechanism, dig into the INCI list before you commit — especially if your skin is sensitive or reactive.
-
Look for meaningful third-party certifications. COSMOS certification (common in European and European-influenced natural skincare products), NSF certification, and “EWG Verified” each require independent ingredient review. They’re not perfect, but they indicate someone beyond the brand itself has examined the formula.
-
Buy from established US retailers rather than gray-market sellers. Products sold through Sephora, Ulta, or major pharmacy chains have typically cleared at least some importer compliance review. Products from overseas-based marketplace sellers or heavy-discount sites may be formulated specifically for the Korean domestic market — with different label requirements, different permitted concentration ranges, and no adaptation for US standards.
-
Report adverse reactions. The FDA’s MedWatch program accepts cosmetic adverse event reports at fda.gov/safety/medwatch. Post-market surveillance is currently the FDA’s primary enforcement mechanism for cosmetics, which means it only functions as a safety net if consumers actually use it.
Natural Skincare Products and the Myth of Global Consistency
The K-beauty example illustrates something broader about the global natural skincare products market: “natural,” “clean,” “dermatologist tested,” and even government-certified do not mean the same thing across borders.
Centella asiatica is natural. So is poison ivy. Botanical ingredients can be potent, sensitizing, comedogenic, or phototoxic — and “plant-derived” is not a synonym for “safe for all skin types at all concentrations.” Some of the best-documented irritants in cosmetic dermatology are naturally occurring compounds. This matters when evaluating K-beauty products that lean heavily on botanical ingredients marketed as gentle, because the evidence base for some of those ingredients’ safety profiles at the concentrations used is thinner than the branding implies.
The gap between the EU’s proactive pre-market system and the US FDA’s historically reactive approach means that as an American consumer, you carry more personal due-diligence responsibility than your counterpart in Paris or Berlin. That’s not a critique of K-beauty specifically — the same is true of US domestic brands, European imports, and everything in between. It’s the structure of US cosmetics regulation. And MoCRA, while a genuine and overdue improvement, hasn’t closed that gap yet.
Knowing which set of rules the product on your shelf actually had to meet is, right now, your most practical tool for navigating it.
Written by Nour Abochama, Host & Quality Control Expert, Nourify & Beautify. Learn more about our team
Have questions about product safety? Talk to our experts Contact us
Related from our network
- Cosmetic ingredient testing and raw material verification — Ayah Labs specializes in supplier qualification and formulation testing for brands seeking true ingredient transparency.
- Third-party label accuracy and contaminant testing — Qalitex Laboratories offers ISO 17025-accredited testing to verify that what’s on a cosmetic label matches what’s actually in the product.
